	What Genzyme's CEO Doesn't Know, and Doesn't Want to Know, About Sanofi's Hostile Bid
	In Sanofi-Genzyme Deal, Both Sides Are Dancing Around Bad Information
	New Genzyme pill will cost patients $310,250 a year
	Genzyme Held Bad News As Shares Dropped - Forbes
	Sanofi to buy Genzyme for more than $20 billion
	How Genzyme became a source of biotech executives
	Genzyme's Going After AnorMED - Forbes
	Genzyme to Buy Ilex Oncology for $1 Billion in Stock Deal